ArticleThe Journal of urology2020

Re: Selective Targeting of PARP-2 Inhibits Androgen Receptor Signaling and Prostate Cancer Growth through Disruption of FOXA1 Function.

Anthony AtalaPubMed ↗Publisher ↗

No numbers read from the abstract.